National Research (NASDAQ:NRC) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $15.84 and traded as high as $18.31. National Research shares last traded at $17.73, with a volume of 135,330 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, March 6th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, National Research presently has a consensus rating of “Sell”.

National Research Trading Down 1.5%

The company has a market capitalization of $393.80 million, a price-to-earnings ratio of 34.62 and a beta of 0.53. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 5.36. The business’s 50 day moving average price is $16.81 and its two-hundred day moving average price is $15.85.

National Research (NASDAQ:NRC) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.16 earnings per share (EPS) for the quarter. National Research had a net margin of 8.44% and a return on equity of 103.84%. The business had revenue of $35.19 million during the quarter.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Investors of record on Friday, March 27th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.7%. National Research’s dividend payout ratio (DPR) is 128.00%.

Hedge Funds Weigh In On National Research

Several large investors have recently bought and sold shares of NRC. EverSource Wealth Advisors LLC boosted its stake in shares of National Research by 9,535.3% during the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock valued at $28,000 after purchasing an additional 1,621 shares in the last quarter. Russell Investments Group Ltd. increased its stake in shares of National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after buying an additional 921 shares during the period. Raymond James Financial Inc. bought a new position in National Research in the 2nd quarter valued at approximately $34,000. PNC Financial Services Group Inc. boosted its position in National Research by 1,072.5% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,087 shares of the company’s stock worth $35,000 after buying an additional 1,909 shares during the period. Finally, BNP Paribas Financial Markets boosted its position in National Research by 85.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after buying an additional 1,150 shares during the period. 47.26% of the stock is currently owned by institutional investors.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.